Green Lifescience's latest marketcap:
As of 06/26/2025, Green Lifescience's market capitalization has reached $45.52 M. According to our data, Green Lifescience is the 30350th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 45.52 M |
| Revenue (ttm) | 16.98 M |
| Net Income (ttm) | -470,004.29 |
| Shares Out | 19.53 M |
| EPS (ttm) | -0.02 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2025 |
Green Lifescience's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | ₩45.52 M | 101.47% | 30350 |
| 12/30/2024 | ₩32.08 B | -27.91% | 33732 |
| 12/28/2023 | ₩44.5 B | -49.97% | 30305 |
| 12/29/2022 | ₩88.95 B | -41.29% | 24561 |
| 12/30/2021 | ₩151.5 B | -17.55% | 21560 |
| 12/30/2020 | ₩183.75 B | 98.54% | 17634 |
| 12/30/2019 | ₩92.55 B | 45.18% | 19320 |
| 12/28/2018 | ₩63.75 B | -0.12% | 20280 |
| 12/28/2017 | ₩63.82 B | -10.52% | 20658 |
| 12/29/2016 | ₩71.32 B | 3.59% | 18567 |
Company Profile
About Green Lifescience Co., Ltd.
Green Lifescience Co., Ltd. specializes in the development, production, and sale of agrochemical raw materials and pharmaceutical intermediates, serving markets in South Korea and internationally.
Core Offerings
- Raw materials for pharmaceuticals and pesticides
- Primary intermediates for pharmaceutical and agrochemical applications
Key Products
- EDP-CL – A piperacillin antibiotic intermediate
- N,N-disuccinimidyl carbonate – Used in HIV treatment synthesis
- Amoxapine – An antidepressant raw drug
- AM19 – An antibiotic intermediate
- 1,1'-carbonyldiimidazole – A pharmaceutical coupling reagent
Company Background
Founded in 2005 and headquartered in Yeosu, South Korea, the company was formerly known as KPX Lifescience Co., Ltd. before rebranding to Green Lifescience Co., Ltd. in June 2022. It operates as a subsidiary of KPX Holdings Co., Ltd.
Frequently Asked Questions
-
What is Green Lifescience's (KOSDAQ-114450) current market cap?As of 06/26/2025, Green Lifescience (including the parent company, if applicable) has an estimated market capitalization of $45.52 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Green Lifescience (KOSDAQ-114450) rank globally by market cap?Green Lifescience global market capitalization ranking is approximately 30350 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.